Swiss early-stage venture capital firm.
Profile being verified
What they look for
Led the USD 3 M round of Scholé AI and the USD 5.4 M seed of Prevision Medicine; Steve Salom, partner, is quoted in both articles.
Recent investments
Recorded Swiss rounds: Scholé AI (stage not specified, USD 3 M, January 2026, lead), Prevision Medicine (seed, USD 5.4 M, September 2026, lead).
Rounds tracked by FundSwiss
- Prevision MedicineSeed · USD 5.4 M
- Adaptyv BiosystemsSeries A · USD 40 M
- Scholé AIUndisclosed round · USD 3 M